ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,263, issued on Nov. 18, was assigned to PANOPTES PHARMA GES.M.B.H (Vienna).
"Ophthalmic formulation" was invented by Stefan Sperl (Vienna) and Franz Obermayr (Vienna).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an ophthalmic composition comprising an active pharmaceutically compound non-covalently bound to albumin. The composition of the present invention is useful for treatment of ophthalmic diseases and disorders."
The patent was filed on March 8, 2019, under Application No. 16/977,973.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO...